Principal Investigator:
Wafaie Fawzi, Professor of Nutrition and Epidemiology



Dates of Research:
September 1, 2005 — June 30, 2011


Access to antiretroviral therapy in developing countries is limited but is gradually becoming the standard of care. The safety and efficacy of micronutrient supplements in the context of antiretroviral therapy have not been established. This study will examine that relationship and disease progression among 3000 HIV positive Tanzanian women and men who are currently on antiretroviral therapy. Research physicians and nurses at the study clinic see study participants on a monthly basis to assess clinical status and undertake study procedures. Each individual will be followed for a minimum of 24 months or maximum of 48 months. Home visits will also be conducted as appropriate. This study is a collaborative effort between Harvard School of Public Health and Muhimbili University College of Health Sciences, Dar-es-Salaam, Tanzania.